Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CANCER BIOLOGY

Targeting BRCA-mutated tumors in mitosis

A genome-wide CRISPR screen finds CIP2A as a new synthetic lethal target for BRCA1- and BRCA2-deficient cells. Unlike PARP inhibition that increases replication-induced DNA double-strand breaks and radial chromosomes, depleting CIP2A or disrupting its interaction with TOPBP1 increases micronuclei and chromosomal missegregation, revealing a mitotic target for BRCA-mutated tumors.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: BRCA1- and BRCA2-deficient cells accumulate DNA damage and breaks in mitosis probably caused by incomplete chromosome replication, particularly in the absence of TP53.

References

  1. Farmer, H. et al. Nature 434, 917–921 (2005).

    CAS  Article  Google Scholar 

  2. Bryant, H. E. et al. Nature 434, 913–917 (2005).

    CAS  Article  Google Scholar 

  3. Lord, C. J. & Ashworth, A. Nat. Med. 19, 1381–1388 (2013).

    CAS  Article  Google Scholar 

  4. Adam, S. et al. Nat. Cancer https://doi.org/10.1038/s43018-021-00266-w (2021).

  5. Mengwasser, K. E. et al. Mol. Cell 73, 885–899 (2019).

    CAS  Article  Google Scholar 

  6. Alvarez-Quilon, A. et al. Mol. Cell 78, 1152–1165 (2020).

    CAS  Article  Google Scholar 

  7. Soofiyani, S. R., Hejazi, M. S. & Baradaran, B. Biomed. Pharmacother. 96, 626–633 (2017).

    CAS  Article  Google Scholar 

  8. Come, C. et al. Clin. Cancer Res. 15, 5092–5100 (2009).

    CAS  Article  Google Scholar 

  9. Junttila, M. R. et al. Cell 130, 51–62 (2007).

    CAS  Article  Google Scholar 

  10. Ventela, S. et al. PLoS ONE 7, e33209 (2012).

    CAS  Article  Google Scholar 

  11. Laine, A. et al. Cancer Res. 81, 4319–4331 (2021).

    CAS  Article  Google Scholar 

  12. Leimbacher, P. A. et al. Mol. Cell 74, 571–583 (2019).

    CAS  Article  Google Scholar 

  13. De Marco Zompit, M. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.02.08.430274 (2021).

  14. Hustedt, N. et al. Open Biol. 9, 190156 (2019).

    CAS  Article  Google Scholar 

  15. Sidi, S. et al. Cell 133, 864–877 (2008).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

D.M. was a senior fellow of the Leukemia & Lymphoma Society. The work is in part supported by NIH1R01CA215067 to S.Z.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shan Zha.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Menolfi, D., Zha, S. Targeting BRCA-mutated tumors in mitosis. Nat Cancer 2, 1296–1297 (2021). https://doi.org/10.1038/s43018-021-00293-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-021-00293-7

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer